Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2003
07/22/2003US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides
07/22/2003CA2275602C Novel carboxy substituted cyclic carboxamide derivatives
07/17/2003WO2003057674A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057672A2 Tetrahydroquinoline analogues as muscarinic agonists
07/17/2003WO2003057669A1 Androgen receptor antagonists
07/17/2003WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use
07/17/2003WO2003057664A1 Carboxamidine derivatives and their use in the treatment of vascular diseases
07/17/2003WO2003057225A2 Phosphate transport inhibitors
07/17/2003WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity
07/17/2003WO2003032962A3 Dual action antibiotics
07/17/2003WO2002006280A3 INHIBITORS OF FACTOR Xa
07/17/2003US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate
07/17/2003US20030135051 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
07/17/2003US20030135044 Novel gamma secretase inhibitors
07/17/2003US20030134876 Inhibiting TNF alpha
07/17/2003US20030134853 Tetrazolyl- and carbamidosulfonyl-substituted 2-phenyl-1-cycloalkyl -benzimidazoles or -imidazo(4,5b)pyridines that inhibit the RNA-dependent RNA polymerase encoded by Hepatitis C
07/17/2003US20030134840 Novel compounds
07/17/2003US20030134836 Substituted arylamine derivatives and methods of use
07/17/2003US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
07/17/2003US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
07/17/2003US20030134148 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
07/17/2003CA2471885A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003CA2471754A1 Androgen receptor antagonist
07/17/2003CA2471752A1 Carboxamidine derivatives and their use in the treatment of vascular diseases
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
07/16/2003EP1326858A2 Piperidine compounds as anti-allergic
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326850A1 A process for the preparation of bis-benzazolyl compounds
07/16/2003EP1326843A1 Pyrazole derivatives for the treatment of viral diseases
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003CN1430612A Hete rocyclic derivatives
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same
07/16/2003CN1114604C Bicyclic aryl carboxamides and their therapeutic use
07/16/2003CN1114598C Aromatic compounds and pharmaceutical compositions containing them
07/16/2003CN1114403C Vitronectin receptor antagonists
07/15/2003USRE38188 Ethylene derivatives and pesticides containing said derivatives
07/15/2003US6593472 NK-1 receptor active amine oxide prodrugs
07/15/2003US6593349 3-(heteroarylamino) indazole, 1,2-benzisothiazole, or 1,2-benzisoxazole derivatives of given formula; for treating nervous system disorders such as pain, anxiety and bipolar disorder
07/15/2003US6593346 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3.
07/15/2003US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases
07/15/2003US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof
07/15/2003US6593330 Compounds and their use
07/15/2003US6593328 Pesticides
07/15/2003US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man.
07/15/2003US6593322 Compounds and methods for modulation of estrogen receptors
07/15/2003US6593013 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
07/15/2003US6592633 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
07/10/2003WO2003055877A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
07/10/2003WO2003055868A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
07/10/2003WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
07/10/2003WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003022274A3 2-aroylimidazole compounds for treating cancer
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
07/10/2003WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
07/10/2003US20030130520 Producing substituted 2-nitro-guanidine derivatives.
07/10/2003US20030130509 Process to produce 3-carbon amino alcohol salts
07/10/2003US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis.
07/10/2003US20030130505 Nonsteroidal agonists and antagonists
07/10/2003US20030130488 An asymmetric catalyst that can epoxidize unsaturated amides or ketones
07/10/2003US20030130328 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
07/10/2003US20030130325 Substituted tryptophan derivatives
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130307 Heterocycles
07/10/2003US20030130306 Abntidiabetic agents, cardiovascular disorders, anticholesterol agents
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130281 DPP IV inhibitors
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130270 Heterocyclic derivatives and their use as antithrombotic agents
07/10/2003US20030130265 Benzimidazole derivatives, a process for their manufacture and use as a medicine
07/10/2003US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
07/10/2003US20030130260 Aryl fused azapolycyclic compounds
07/10/2003US20030130259 Quinoline and quinazoline compounds useful in therapy
07/10/2003US20030130253 Central nervous system disorders; skin disorders; appetite suppressants
07/10/2003US20030130251 Blocking amyloid deposits; Alzheimer's disease, Down syndrome
07/10/2003US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
07/10/2003US20030130204 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis
07/10/2003CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
07/09/2003EP1325925A1 Chromium catalysts active in olefin polymerization
07/09/2003EP1325920A1 N-substituted benzothiophenesulfonamide derivatives
07/09/2003EP1325916A1 Piperazinyl-substituted phenyl pyrimidine derivatives useful in the treatment or prevention of disorders of the central nervous system
07/09/2003EP1325910A1 Aliphatic nitrogenous five-membered ring compounds
07/09/2003EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
07/09/2003EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
07/09/2003EP1324991A1 Compounds useful in the treatment of inflammatory diseases
07/09/2003EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
07/09/2003EP1165496B1 Substituted aniline compounds
07/09/2003EP0966465B1 Inhibitors of impdh enzyme
07/09/2003CN1429226A Piperazine and piperidine compounds
07/09/2003CN1429222A 激酶抑制剂 Kinase inhibitors
07/09/2003CN1429215A 三唑衍生物 Triazole derivatives
07/09/2003CN1429210A Substituted thioacetamides
07/09/2003CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/09/2003CN1113603C Azine derivatives
07/08/2003US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits